World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
50763
World Ranking
5296
National Ranking
55

Gunnar H. Gislason publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gunnar H. Gislason sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,178 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gunnar H. Gislason D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gunnar H. Gislason sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gunnar H. Gislason is affiliated with Copenhagen University Hospital in Denmark. Their research output spans multiple areas within medicine, with a focus on cardiology and cardiovascular medicine.

The scientist's recent publications include:

  • Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality, 2020, JAMA
  • Cardiovascular effects and safety of (non-aspirin) NSAIDs, 2020, Nature Reviews Cardiology
  • SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study, 2021, BMJ
  • Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction, 2020, Circulation
  • Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome, 2020, Journal of the American College of Cardiology

They frequently collaborate with several co-authors, including:

  • Christian Torp-Pedersen
  • Lars Køber
  • Emil Loldrup Fosbøl
  • Tor Biering-Sørensen
  • Morten Schou

The primary publication venues for their work are:

  • European Heart Journal
  • Journal of the American College of Cardiology
  • Circulation
  • EP Europace
  • Journal of the American Heart Association

Gislason's research focuses mainly on medicine, with subfields including:

  • Cardiology and Cardiovascular Medicine
  • Epidemiology
  • Emergency Medicine
  • Endocrinology, Diabetes and Metabolism
  • Surgery

The key topics of their scientific work encompass:

  • Cardiovascular Function and Risk Factors
  • Atrial Fibrillation Management and Outcomes
  • Heart Failure Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrest and Resuscitation
  • Cardiac Arrhythmias and Treatments
  • Acute Myocardial Infarction Research

Best Publications

  • Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

    Jonas Bjerring Olesen;Gregory Y H Lip;Morten Lock Hansen;Peter Riis Hansen

  • Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest

    Mads Wissenberg;Freddy K. Lippert;Fredrik Folke;Peter Weeke

  • Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

    Jonas Bjerring Olesen;Gregory Y H Lip;Anne-Lise Kamper;Kristine Hommel

  • Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.

    Morten L. Hansen;Rikke Sørensen;Mette T. Clausen;Marie Louise Fog-Petersen

  • Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

    Rikke Sørensen;Morten L Hansen;Steen Z Abildstrom;Steen Z Abildstrom;Anders Hvelplund

  • Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People

    Tina Ken Schramm;Gunnar H. Gislason;Lars Køber;Søren Rasmussen

  • Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

    Gunnar H. Gislason;Søren Jacobsen;Jeppe N. Rasmussen;Søren Rasmussen

  • Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

    Jonas Bjerring Olesen;Gregory Y H Lip;Jesper Lindhardsen;Deirdre A Lane

  • Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention A Nationwide Cohort Study

    Morten Lamberts;Jonas Bjerring Olesen;Martin Huth Ruwald;Carolina Malta Hansen

  • Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

    Tina Ken Schramm;Gunnar Hilmar Gislason;Allan Vaag;Jeppe Nørgaard Rasmussen

  • Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.

    O. Ahlehoff;G. H. Gislason;M. Charlot;C. H. Jørgensen

  • The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study

    Jesper Lindhardsen;Ole Ahlehoff;Gunnar Hilmar Gislason;Ole Rintek Madsen

  • Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study

    Anne-Marie Schjerning Olsen;Emil L. Fosbøl;Jesper Lindhardsen;Fredrik Folke

  • Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

    Morten Lamberts;Gunnar H. Gislason;Jonas Bjerring Olesen;Søren Lund Kristensen

  • Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.

    Emil L. Fosbøl;Jawad H. Butt;Lauge Østergaard;Charlotte Andersson

  • Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction

    Gunnar H. Gislason;Jeppe N. Rasmussen;Steen Z. Abildstrøm;Niels Gadsbøll

  • The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study

    Christian Selmer;Jonas Bjerring Olesen;Morten Lock Hansen;Jesper Lindhardsen

  • Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.

    Gunnar H. Gislason;Jeppe N. Rasmussen;Steen Z. Abildstrom;Tina K. Schramm

  • Bystander Efforts and 1-Year Outcomes in Out-of-Hospital Cardiac Arrest.

    Kristian Kragholm;Kristian Kragholm;Mads Wissenberg;Rikke N. Mortensen;Steen M. Hansen

  • Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.

    Mette Charlot;Ole Ahlehoff;Mette Lykke Norgaard;Casper H. Jørgensen

Frequent Co-Authors

Christian Torp-Pedersen
Christian Torp-Pedersen Aalborg University
Lars Køber
Lars Køber Copenhagen University Hospital
Peter Riis Hansen
Peter Riis Hansen University of Copenhagen
Lone Skov
Lone Skov University of Copenhagen
Jacob P. Thyssen
Jacob P. Thyssen University of Copenhagen
Gregory Y.H. Lip
Gregory Y.H. Lip University of Liverpool
Mark A. Hlatky
Mark A. Hlatky Stanford University
Henrik E. Poulsen
Henrik E. Poulsen University of Copenhagen
Allan Vaag
Allan Vaag Steno Diabetes Center
Jonathan M. Hodgson
Jonathan M. Hodgson Edith Cowan University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine but prefer more flexible study options, numerous online degrees can help you enter or advance in healthcare. One popular path is pursuing nurse practitioner programs, which allow registered nurses to gain advanced clinical skills while working.

For those starting with an RN license, the cheapest rn to bsn online programs offer cost-effective ways to earn a Bachelor of Science in Nursing (BSN). This degree can broaden job opportunities and is a common requirement for leadership positions in nursing.

Nurses seeking to reach the highest academic level can explore the cheapest phd nursing programs online. These rigorous degrees focus on research and leadership, opening doors to careers in academia, advanced practice, or administration.

If affordability is a priority, there are many affordable rn to bsn programs designed to provide quality education without high tuition costs. Choosing a pathway that matches your career goals and budget can set you on the right trajectory in healthcare.

Best Scientists Citing Gunnar H. Gislason

Trending Scientists

Recently Published Articles